5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

Published:2011 Issue:5-6 Volume:80 Page:301-306
ISSN:1423-0232
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Assaf Elias,Verlinde-Carvalho Muriel,Delbaldo Catherine,Grenier Julien,Sellam Zineb,Pouessel Damien,Bouaita Linda,Baumgaertner Isabelle,Sobhani Iradj,Tayar Claude,Paul Muriel,Culine Stéphane

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference36 articles.

1. Cancer Statistics, 2003

2. EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary

3. Chemotherapy prolongs survival in inoperable pancreatic carcinoma

4. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

5. Present and future treatment of pancreatic cancer

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumoroid-on-a-Plate (ToP): Physiologically Relevant Cancer Model Generation and Therapeutic Screening;2024-04-19

2. Clinical practice guidelines for interventional treatment of pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

3. Updates of Chemotherapy for Pancreatic Cancer;Journal of Digestive Cancer Research;2023-12-20

4. Systemic therapy for metastatic pancreatic cancer;Malignant tumours;2023-10-09

5. Prácticas de transparencia y reproducibilidad en artículos de revistas españolas de Biblioteconomía y Documentación;Revista Española de Documentación Científica;2023-07-06